Landscapes / Diabetes Mellitus

Insulin-Dependent Diabetes Mellitus 12

16 drugs in active Insulin-Dependent Diabetes Mellitus 12 trials · Updated 18 Nov 2026

Furthest along
2 in Phase 3
8 in Phase 2
Next Phase 3 result
Jan 2027
Drugs
16
In active trials, any stage
Trials
15 active
No sub-diseases

Drugs16

DrugHow it worksCompanyStageNext dateDetails
—
Phase 3 Jan 2027Phase 3 trial completes
Monoclonal antibody
Phase 3 —
Monoclonal antibody
Phase 2 Sep 2027Phase 2 trial completes
Monoclonal antibody
Phase 2 Sep 2027Phase 2 trial completes
—
CSPC · Public 1093.HK
Phase 1/2 3 Feb 2029Phase 1/2 trial completes
GB268not checked
—
Phase 1/2 1 Aug 2029Phase 1/2 trial completes
Artificial immunoglobulin
Phase 2 30 Sep 2029Phase 2 trial completes
—
Phase 1/2 —
PD-1 antibody
Merck & Co. · Public MRK
Phase 1/2 —
CTLA-4 antibody
AstraZeneca · Public AZN
Phase 2 —

See all 16 drugs

Sign in free to see the whole list. No card, no password.

Sign in free

How trials write it5

The conditions trials list that we place on Insulin-Dependent Diabetes Mellitus 12 itself, with their active trials

Solid Tumor Cancer 16Advanced Clear Cell Renal Cell Carcinoma 3Healthy Male Volunteers 1Advanced Or Metastatic Solid Tumor Malignancies 1Metastatic Sarcoma 1

About

Summary
16 drugs are in active Insulin-Dependent Diabetes Mellitus 12 trials: 2 in Phase 3, 14 earlier. The next Phase 3 result expected is BCD-217’s, Jan 2027. Updated 18 Nov 2026.
Registry term
Diabetes Mellitus, Insulin-Dependent, 12
Counts
Active trials the registry tags with the term or a term under it, at any stage. A search also reads trial titles and drug names, so its counts differ.
Sources
ClinicalTrials.gov updated 18 Nov 2026